Imbalanced signaling between maternal and placental cells contributes to preeclampsia, suggests a new study in human tissues and mice [1] .
Women with preeclampsia are known to have elevated serum levels of sFLT1 (soluble FMS-like tyrosine kinase 1), which is thought to promote disease. Overexpression of sFLT1 in mice produces preeclampsia symptoms, and-in a small pilot study-removal of circulating sFLT1 reduced symptoms in women with preeclampsia. sFLT1 is a soluble receptor of the pro-angiogenic factor VEGF (vascular endothelial growth factor) and acts as a potent VEGF antagonist.
It is unclear what drives the spike in sFLT1 levels in preeclampsia. Xiujun Fan and colleagues now report that excess VEGF in maternal cells prompts sFLT1 overexpression in embryo-derived trophoblast cells in preeclampsia. The rise in sFLT1 seems to protect the fetus against excessive VEGF, revealing an unexpected beneficial effect of the receptor.
The researchers found that VEGF was expressed in human maternal decidual cells, and that sFLT1 was expressed in adjacent placental trophoblasts. Both molecules were found at higher levels in these cells in preeclamptic women. The researchers next asked if VEGF in the decidual cells could be driving the excess production of sFLT1. Overcoming several technical hurdles, the researchers created mice with excess expression of VEGF specifically in the mouse endometrium. These mice produced excess sFLT1 in placental trophoblasts in later stages of pregnancy and had typical symptoms of preeclampsia-including maternal hypertension, glomerular endotheliosis, and proteinuria. It seems that excess VEGF itself contributes to preeclampsia, and removing sFLT1 in the presence of excess VEGF causes serious vascular defects in the placenta and fetal death.
The researchers propose that sFLT1 levels rise in the placenta to counteract excess endometrial VEGF in preeclampsia. The findings sound a cautionary note for human studies altering the levels of sFLT1 or VEGF, since the mice in this study were very sensitive to even minor shifts in levels of these regulators.
